Svetlana Lucas
Direttore/Membro del Consiglio presso ATYR PHARMA, INC.
Patrimonio netto: 10 380 $ in data 31/05/2024
Posizioni attive di Svetlana Lucas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATYR PHARMA, INC. | Direttore/Membro del Consiglio | 28/06/2019 | - |
| Independent Dir/Board Member | 28/06/2019 | - | |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - | - |
Storia della carriera di Svetlana Lucas
Precedenti posizioni note di Svetlana Lucas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/07/2015 | 01/06/2019 |
| AMGEN INC. | Corporate Officer/Principal | 01/08/2014 | 01/07/2015 |
Formazione di Svetlana Lucas
| California Institute of Technology | Doctorate Degree |
| Moscow State University Lomonosov | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Russia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Health Technology |
- Borsa valori
- Insiders
- Svetlana Lucas
- Esperienza
